Rhythm Biosciences Limited (FRA:0RY)

Germany flag Germany · Delayed Price · Currency is EUR
0.0415
-0.0015 (-3.49%)
At close: Dec 4, 2025
-17.00%
Market Cap 14.53M
Revenue (ttm) 1.78M
Net Income (ttm) -2.14M
Shares Out n/a
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.0415
Previous Close 0.0430
Day's Range 0.0415 - 0.0415
52-Week Range 0.0270 - 0.0720
Beta n/a
RSI 38.03
Earnings Date Feb 18, 2026

About Rhythm Biosciences

Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States. It offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. The company was incorporated in 2017 and is headquartered in Parkville, Australia. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2017
Country Australia
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 0RY
Full Company Profile

Financial Performance

In 2025, Rhythm Biosciences's revenue was 3.19 million, an increase of 88.85% compared to the previous year's 1.69 million. Losses were -3.83 million, -44.15% less than in 2024.

Financial numbers in AUD Financial Statements

News

There is no news available yet.